<?xml version='1.0' encoding='utf-8'?>
<document id="19704026"><sentence text="In vivo evaluation of drug-drug interaction via mechanism-based inhibition by macrolide antibiotics in cynomolgus monkeys." /><sentence text="Irreversible inhibition, characterized as mechanism-based inhibition (MBI), of cytochrome P450 in drugs has to be avoided for their safe use" /><sentence text=" A comprehensive assessment of drug-drug interaction (DDI) potential is important during the drug discovery process" /><sentence text=" In the present study, we evaluated the effects of macrolide antibiotics, erythromycin (ERM), clarithromycin (CAM), and azithromycin (AZM), which are mechanism-based inhibitors of CYP3A, on biotransformation of midazolam (MDZ) in monkeys"><entity charOffset="74-86" id="DDI-PubMed.19704026.s4.e0" text="erythromycin" /><entity charOffset="88-91" id="DDI-PubMed.19704026.s4.e1" text="ERM" /><entity charOffset="94-108" id="DDI-PubMed.19704026.s4.e2" text="clarithromycin" /><entity charOffset="110-113" id="DDI-PubMed.19704026.s4.e3" text="CAM" /><entity charOffset="120-132" id="DDI-PubMed.19704026.s4.e4" text="azithromycin" /><entity charOffset="134-137" id="DDI-PubMed.19704026.s4.e5" text="AZM" /><entity charOffset="211-220" id="DDI-PubMed.19704026.s4.e6" text="midazolam" /><entity charOffset="222-225" id="DDI-PubMed.19704026.s4.e7" text="MDZ" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e0" e2="DDI-PubMed.19704026.s4.e0" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e0" e2="DDI-PubMed.19704026.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e0" e2="DDI-PubMed.19704026.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e0" e2="DDI-PubMed.19704026.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e0" e2="DDI-PubMed.19704026.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e0" e2="DDI-PubMed.19704026.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e0" e2="DDI-PubMed.19704026.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e0" e2="DDI-PubMed.19704026.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e1" e2="DDI-PubMed.19704026.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e1" e2="DDI-PubMed.19704026.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e1" e2="DDI-PubMed.19704026.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e1" e2="DDI-PubMed.19704026.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e1" e2="DDI-PubMed.19704026.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e1" e2="DDI-PubMed.19704026.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e1" e2="DDI-PubMed.19704026.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e2" e2="DDI-PubMed.19704026.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e2" e2="DDI-PubMed.19704026.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e2" e2="DDI-PubMed.19704026.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e2" e2="DDI-PubMed.19704026.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e2" e2="DDI-PubMed.19704026.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e2" e2="DDI-PubMed.19704026.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e3" e2="DDI-PubMed.19704026.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e3" e2="DDI-PubMed.19704026.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e3" e2="DDI-PubMed.19704026.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e3" e2="DDI-PubMed.19704026.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e3" e2="DDI-PubMed.19704026.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e4" e2="DDI-PubMed.19704026.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e4" e2="DDI-PubMed.19704026.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e4" e2="DDI-PubMed.19704026.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e4" e2="DDI-PubMed.19704026.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e5" e2="DDI-PubMed.19704026.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e5" e2="DDI-PubMed.19704026.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e5" e2="DDI-PubMed.19704026.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e6" e2="DDI-PubMed.19704026.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19704026.s4.e6" e2="DDI-PubMed.19704026.s4.e7" /></sentence><sentence text=" These macrolides inhibited the formation of 1'-hydroxymidazolam in monkey microsomes as functions of incubation time and macrolide concentration"><entity charOffset="45-64" id="DDI-PubMed.19704026.s5.e0" text="1'-hydroxymidazolam" /><entity charOffset="122-131" id="DDI-PubMed.19704026.s5.e1" text="macrolide" /><pair ddi="false" e1="DDI-PubMed.19704026.s5.e0" e2="DDI-PubMed.19704026.s5.e0" /><pair ddi="false" e1="DDI-PubMed.19704026.s5.e0" e2="DDI-PubMed.19704026.s5.e1" /></sentence><sentence text=" Furthermore, the inactivation potentials of macrolides (k(inact)/K(I): CAM congruent with ERM &gt; AZM) were as effective as that observed in human samples"><entity charOffset="91-99" id="DDI-PubMed.19704026.s6.e0" text="ERM" /><entity charOffset="72-80" id="DDI-PubMed.19704026.s6.e1" text="CAM" /><entity charOffset="97-105" id="DDI-PubMed.19704026.s6.e2" text="AZM" /><pair ddi="false" e1="DDI-PubMed.19704026.s6.e1" e2="DDI-PubMed.19704026.s6.e1" /><pair ddi="false" e1="DDI-PubMed.19704026.s6.e1" e2="DDI-PubMed.19704026.s6.e0" /><pair ddi="false" e1="DDI-PubMed.19704026.s6.e1" e2="DDI-PubMed.19704026.s6.e2" /><pair ddi="false" e1="DDI-PubMed.19704026.s6.e0" e2="DDI-PubMed.19704026.s6.e0" /><pair ddi="false" e1="DDI-PubMed.19704026.s6.e0" e2="DDI-PubMed.19704026.s6.e2" /></sentence><sentence text=" In in vivo studies, MDZ was administered orally (1 mg/kg) without or with multiple oral dosing of macrolides (15 mg/kg, twice a day on days 1-3)"><entity charOffset="21-23" id="DDI-PubMed.19704026.s7.e0" text="MDZ" /></sentence><sentence text=" On day 3, the area under the plasma concentration-time curve (AUC) of MDZ increased 7"><entity charOffset="71-73" id="DDI-PubMed.19704026.s8.e0" text="MDZ" /></sentence><sentence text="0-, 9" /><sentence text="9-, and 2" /><sentence text="0-fold with ERM, CAM, and AZM, respectively, compared with MDZ alone"><entity charOffset="12-14" id="DDI-PubMed.19704026.s11.e0" text="ERM" /><entity charOffset="17-19" id="DDI-PubMed.19704026.s11.e1" text="CAM" /><entity charOffset="26-28" id="DDI-PubMed.19704026.s11.e2" text="AZM" /><entity charOffset="59-61" id="DDI-PubMed.19704026.s11.e3" text="MDZ" /><pair ddi="false" e1="DDI-PubMed.19704026.s11.e0" e2="DDI-PubMed.19704026.s11.e0" /><pair ddi="false" e1="DDI-PubMed.19704026.s11.e0" e2="DDI-PubMed.19704026.s11.e1" /><pair ddi="false" e1="DDI-PubMed.19704026.s11.e0" e2="DDI-PubMed.19704026.s11.e2" /><pair ddi="false" e1="DDI-PubMed.19704026.s11.e0" e2="DDI-PubMed.19704026.s11.e3" /><pair ddi="false" e1="DDI-PubMed.19704026.s11.e1" e2="DDI-PubMed.19704026.s11.e1" /><pair ddi="false" e1="DDI-PubMed.19704026.s11.e1" e2="DDI-PubMed.19704026.s11.e2" /><pair ddi="false" e1="DDI-PubMed.19704026.s11.e1" e2="DDI-PubMed.19704026.s11.e3" /><pair ddi="false" e1="DDI-PubMed.19704026.s11.e2" e2="DDI-PubMed.19704026.s11.e2" /><pair ddi="false" e1="DDI-PubMed.19704026.s11.e2" e2="DDI-PubMed.19704026.s11.e3" /></sentence><sentence text=" Furthermore, the effects of ERM and CAM on the pharmacokinetics of MDZ were also observed on the day (day 4) after completion of macrolide treatments (AUC changes: 7"><entity charOffset="130-139" id="DDI-PubMed.19704026.s12.e0" text="macrolide" /><entity charOffset="29-37" id="DDI-PubMed.19704026.s12.e1" text="ERM" /><entity charOffset="37-45" id="DDI-PubMed.19704026.s12.e2" text="CAM" /><entity charOffset="68-76" id="DDI-PubMed.19704026.s12.e3" text="MDZ" /><pair ddi="false" e1="DDI-PubMed.19704026.s12.e1" e2="DDI-PubMed.19704026.s12.e1" /><pair ddi="false" e1="DDI-PubMed.19704026.s12.e1" e2="DDI-PubMed.19704026.s12.e2" /><pair ddi="false" e1="DDI-PubMed.19704026.s12.e1" e2="DDI-PubMed.19704026.s12.e3" /><pair ddi="false" e1="DDI-PubMed.19704026.s12.e1" e2="DDI-PubMed.19704026.s12.e0" /><pair ddi="false" e1="DDI-PubMed.19704026.s12.e2" e2="DDI-PubMed.19704026.s12.e2" /><pair ddi="false" e1="DDI-PubMed.19704026.s12.e2" e2="DDI-PubMed.19704026.s12.e3" /><pair ddi="false" e1="DDI-PubMed.19704026.s12.e2" e2="DDI-PubMed.19704026.s12.e0" /><pair ddi="false" e1="DDI-PubMed.19704026.s12.e3" e2="DDI-PubMed.19704026.s12.e3" /><pair ddi="false" e1="DDI-PubMed.19704026.s12.e3" e2="DDI-PubMed.19704026.s12.e0" /></sentence><sentence text="3- and 7" /><sentence text="3-fold, respectively)" /><sentence text=" Because the plasma concentrations of macrolides immediately before MDZ administration on day 4 were much lower than the IC(50) values for reversible CYP3A inhibition, the persistent effects may be predominantly caused by CYP3A inactivation"><entity charOffset="68-70" id="DDI-PubMed.19704026.s15.e0" text="MDZ" /></sentence><sentence text=" These results suggest that the monkey might be a suitable animal model to predict DDIs caused by MBI of CYP3A" /><sentence text="" /></document>